Horses develop pronounced disturbances of gas exchange during anesthesia and recumbency. These disturbances are characterized by an increase in PaCO2 attributable to hypoventilation and by an increase in the (P[A–a]O2).1 The latter results in a low PaO2 despite high FIO2.1,2 The main causes of hypoxemia during anesthesia are pulmonary ventilation-perfusion mismatches attributable to atelectasis and zones of low ventilation at relative overperfusion caused by hydrostatic forces.1,3 A marked increase in venous admixture, which can represent up to 51% of CO, has been detected in horses.4,a These changes are more pronounced in horses in dorsal recumbency than in lateral recumbency,1,3–6 are positively related to body mass,7 and are dependent on the shape of the thoracoabdominal contour.8 This disturbance of gas exchange also exists in ponies. Computed tomography in ponies with a body weight of approximately 100 kg reveals early development of large densities in dependent lung regions.9 These densities have been identified as atelectasis, and a significant association between their area on CT images and the degree of venous admixture can be detected.9 Similar findings were detected in sheep.10
In humans, general anesthesia may also be associated with arterial hypoxemia. Intraoperative atelectasis was suggested to be the major cause of alterations in gas exchange,11,12 and atelectatic lung areas were detected in 87% of anesthetized adults.12 Results of clinical studies13,14 in humans indicate that for a complete reopening of all collapsed lung tissue, an inflation pressure of 40 cm H2O held for 15 seconds was required.13,14 Lachmann15 suggested that atelectatic human lungs could be opened by sufficient PIP and can be prevented from collapsing again by immediate application of PEEP. In this way, more lung tissue becomes available for gas exchange with beneficial effects on lung compliance and oxygenation. The basic principles of the open lung concept were used to develop an alveolar recruitment strategy for patients with healthy but partially collapsed lungs.16,17 The effects of this strategy and variations thereof on arterial oxygenation and lung compliance have since been detected in clinical set-16,18,19 Furthermore, recruiting the lung while preventing derecruitment decreases the potential for ven-tilator-induced lung injury by avoiding the shear stresses associated with a repetitive opening and closing of unstable lung alveoli.20–24 Consequently, alveolar RMs have become accepted as an important part of a lung protective ventilation strategy in humans with ARDS, with significantly improved survival rates.25
The application of high peak inspiratory pressure for an RM and high sustained airway pressure attributable to PEEP carries the risk of barotrauma, alveolocapillary injury,26,27 and hemodynamic compromise. In humans, a PEEP >10 cm H2O significantly decreases the CI,28 CO, and hepatic plasma flow.29 In pigs, a marked transient impairment of hemodynamics has been detected during administration of a sustained PIP of 40 cm H2O. This was associated with decreased blood flow in the celiac artery, cranial mesenteric artery, renal arteries, and portal vein.30 Positive end-expiratory pressure is therefore adjusted to the lowest pressure that prevents alveolar derecruitment. In humans, this corresponds usually to 10 to 20 cm H2O.16,31,32 Determination of the minimal open lung PEEP is determined on the basis of careful monitoring for decreases in arterial oxygenation33 and lung compliance during decremental PEEP titration.34,35
Hypoxemia has long been recognized as a common and potentially hazardous adverse effect of anesthesia in horses, and many attempts have been made for its prevention. Intermittent positive pressure ventilation can correct hypoventilation and normalize PaCO2.4,6 However, in practice, IPPV is often not effective in improving PaO2.1,2,36 Because atelectasis is thought to play an important role in the genesis of hypoxemia during general anesthesia in horses, the combination of IPPV and PEEP has been advocated to prevent atelectasis formation or to reopen atelectatic lung regions. Positive end-expiratory pressure in combination with IPPV has been studied in anesthetized37,38,b and ponies9,39 and has variable and limited effects on oxygenation. In horses, as in other species, IPPV strongly interferes with cardiovascular function36,40,41 There are marked additional depressing effects on cardiovascular parameters when IPPV is combined with PEEP,37,38,42 decreasing CO by as much as 50%.39 The purpose of the study reported here was to evaluate pulmonary and cardiovascular effects of an RM combined with PEEP during TIVA in ponies.
Materials and Methods
Ponies—The study was approved by the local Ethics Committee for Animal Experiments. Six male Shetland ponies from 3 to 5 years old were used in the study. Mean ± SD body weight of ponies was 133 ± 18.3 kg. Ponies were chosen from a convenience sample and were considered healthy as determined by results of clinical examination, CBC, and serum biochemical analyses. Food was withheld for 12 hours prior to anesthesia; access to water was not restricted. All ponies had the left carotid artery surgically relocated to a subcutaneous position 6 months before the study.
Anesthesia technique—Ponies were premedicated with detomidinec (10 μg/kg, IV) to permit insertion of a Swan-Ganz–type catheter.d Anesthesia was induced via this catheter (central venous port) by use of climazolame (0.06 mg/kg, IV) and ketaminef (2.2 mg/kg, IV). After tracheal intubation with a 16-mm-diameter endotracheal tube, ponies were connected to a circle systemg operating in semiclosed mode, with an O2 flow of 4 L/min. The anesthesia circuit had been checked for leaks at 60 cm H2O before each experiment. The cuff was inflated until a leak-proof seal was obtained. Anesthesia was maintained by continuous IV infusion of detomidine, ketamine, and climazolam delivered by a volumetric pumph (1 g of ketamine, 15 mg of climazolam, and 10 mg of detomidine were dissolved in 500 mL of sterile isotonic saline [0.9% NaCl] solution). The TIVA infusion rate was maintained at 0.02 mL/kg/min and corresponded to infusions of detomidine at a rate of 0.024 mg/kg/h, ketamine at a rate of 2.4 mg/kg/h, and climazolam at a rate of 0.036 mg/kg/h. Lactated Ringer's solutioni was administered at a rate of 10 mL/kg/h during induction of anesthesia and was maintained throughout the study.
Ponies were placed on a padded table and positioned in dorsal recumbency. The FIO2 was set at 1.0 throughout the study. Mechanical ventilation was performed by use of a modified human ventilatorj functioning in the pressure-con-trolled mode. At the end of the study, 20 minutes after TIVA was discontinued, the effects of climazolam were antagonized with sarmazenilk (0.04 mg/kg, IV).
Instrumentation—In standing sedated ponies, pulmonary artery catheterization was performed with a special transducer via the right jugular vein during local anesthesia (lidocainel). The tip of the continuous thermodilution Swan-Ganz catheterd (flow-directed balloon-tipped pulmonary artery catheter) was placed in the pulmonary artery by use of pressure waveform analysis. The pulmonary artery catheter is modified to locate a 10-cm thermal filament in the right ventricle during use. The thermal filament continually transfers a safe level of heat directly into the blood. The resulting temperature changes are detected at the distal thermistor located in the catheter. These data are collected and calculated by computer; CO is computed from the area under the curve by use of an equation similar to that used for standard bolus thermodilution. After induction of anesthesia, the transverse facial artery or the left carotid artery was cannulated with a 20-gauge over-the-needle polypropylene catheterm for invasive blood pressure monitoring and arterial blood sampling. The arterial and the pulmonary artery catheters were connected to calibrated pressure transducers via fluid-filled extension lines. Pressure transducers were positioned at the level of the sternal manubrium after ponies were positioned in dorsal recumbency.
Measured and calculated parameters—Respiratory gas flows, volumes, and pressures were measured by use of an electronic spirometric system. The sensor, located between the endotracheal tube and the Y-piece, was connected to dedicated software for data display and post hoc data analysisn (breath-by-breath analysis, body temperature and pressure, saturated[BTPS]). The PIP, PEEP, VT, and expired VM were measured. The Cdyn was automatically calculated as (VT)/(PIP – PEEP). The FIO2, end-tidal O2, and end-tidal CO2 in the respiratory gas were continuously measured° via sampling from the distal part of the endotracheal tube. Cardiovascular monitoring consisted of measurement of the HR derived from the ECG in a base-apex configuration, CCO,d and arterial blood pressure. The CI was calculated by dividing the CO (mL/min) by the body weight (kg) of each pony. By use of 3-way taps, arterial and mixed-venous blood samples for measurements of Pa-O2, PvO2, PaCO2, (P[A-a]O-2), SaO2, and SvO2 and for determination of the Hb concentration were anaerobically collected in 2-mL syringes containing heparin. Samples were collected during at least 2 breathing cycles from the transverse facial or carotid artery and the pulmonary artery, respectively; stored on ice; and analyzed within 30 minutes. These variables were measured by use of conventional electrode techniquesp and corrected to the blood temperature and hemoglobin concentration of each pony, and (P[A-a]O2) was calculated. Alveolar oxygen tension (PAO2) and shunt fraction were calculated by use of the standard oxygen equation43:
where Cc'O2 is the pulmonary end capillary oxygen content, Ca O2 is the arterial oxygen content, CvO2 is the mixed venous oxygen content, PB is the barometric pressure, and Pc'O2 is the pulmonary end capillary partial pressure of oxygen.
RM—After spontaneous breathing, mechanical ventilation began at a PIP of 20 cm H2O and a PEEP of 0 cm H2O (P 20/0, baseline IPPV). The RM was preceded by an incremental PEEP titration phase and followed by a decremental PEEP titration phase, both at a ΔP of 20 cm H2O (Figure 1). The proper RM consisted of a stepwise increase in ΔP by 25, 30, and 35 cm H2O obtained by increasing PIP to 45, 50, and finally 55 cm H2O, while maintaining PEEP at 20 cm H2O. The subsequent decremental PEEP titration phase was initiated with an abrupt decline in PIP to 40 cm H2O (P 40/20). Thereafter, PIP and PEEP were uniformly decreased in steps of 5 cm H2O (P 35/15, P 30/10, and P 25/5) and ended with IPPV (final IPPV).
Each pressure was maintained for 3 minutes. When starting the RM, respiratory frequency was decreased to 6 breaths/min with an inspiration-to-expiration ratio of 1:1 to avoid an excessive decrease in PaCO2 that accompanies increased alveolar ventilation.
Study protocol—Between premedication and induction of anesthesia, the Swan-Ganz catheter was introduced and the first standing CCO was measured. After induction of anesthesia, ponies were breathing spontaneously for 60 minutes before IPPV began. Measurements obtained after 20 minutes of IPPV were considered as baseline values to study the effects of the subsequent PEEP titration–RM and included ventilation and cardiovascular parameters with blood gas values. During the PEEP titration–RM sequence, respiratory and cardiovascular measurements were obtained at the end of each 3-minute step of the procedure and once after the end of the sequence during IPPV.
Statistical analysis—Hemodynamic and pulmonary variables are given as median values and ranges. They were analyzed by use of descriptive statistics and the Wilcoxon signed rank test. For analysis of PaO2, (P[A–a]O2), Cdyn, and shunt, the Wilcoxon signed rank test was used to determine differences between baseline and observed maximal values of the sampling point median. For other cardiovascular and respiratory data, the same test was used to analyze differences between median baseline and median values at maximal airway pressure of the RM and between median values at maximal airway pressure and at the final IPPV. The Wilcoxon signed rank test was also used for comparison of data obtained at baseline IPPV and at final IPPV as well as for identical PEEP levels before and after the RM. For all tests, a value of P < 0.05 was considered significant.
Results
Duration from sedation to induction of anesthesia ranged from 10 to 25 minutes. During this time, the Swan-Ganz catheter was inserted and the first standing CO measurement was performed. Anesthesia was induced in all ponies without complications, and a stable plane of anesthesia was maintained, which was characterized by minor variations in HR, MAP, and respiratory rate and clinical signs such as palpebral reflex, globe position, tear production, and muscular jaw tone. Throughout the study, no inotropes were administered. Mean total duration of anesthesia was 173 minutes (range, 160 to 180 minutes) and included the period from induction of anesthesia to extubation. In each pony, the RM was completed without major hemodynamic complications. No abnormalities were detected during clinical examination of ponies performed the next day. The PEEP titration–RM sequence lasted a mean of 33 minutes and began with the airway setting of P 25/5 in the incremental PEEP titration phase and ended with the final IPPV period.
The VT and VM were maximal during highest airway pressures. At baseline, VT was 14 mL/kg and was increased to 23 mL/kg at maximal airway pressure (P 55/20) when the lungs were actively recruited (Table 1). At final IPPV, a VT of 16 mL/kg was measured. There was a concomitant significant (P = 0.03) increase in VM recorded at baseline (8.6 L) and at P 55/20 (16.3 L). Compared with baseline, VM (8.6 L) was significantly (P = 0.03) increased after completion of the RM (12.4 L at the final IPPV period). The maximal valuesof Cdyn and PaO2 and minimal values of shunt and (P[A–a]O2) were recorded during the decremental phase of the PEEP titration (Figure 2). The Cdyn increased significantly (P = 0.03) from baseline 90.5 mL/cm H2O to a maximal value of 147 mL/cm H2O measured at P 30/10 in the decremental PEEP titration phase. After the RM at final IPPV, Cdyn continued to be significantly (P = 0.03) higher than at baseline (120.4 vs 90.5 mL/cm H2O). At all pressure steps during the decremental PEEP titration after the RM, Cdyn was significantly (all P = 0.03) higher than during the respective pressure steps of the incremental phase. The PaO2 increased from a baseline value of 441.3 mm Hg to a maximal value of 495.1 mm Hg measured at P 35/15 during the decremental PEEP titration phase; the increase from baseline was significant (P = 0.03) at the next lower step of the decremental PEEP titration (479.1 mm Hg at P 30/10). The PaO2 decreased to 445.2 mm Hg at final IPPV. When compared with the incremental PEEP titration phase, PaO2 at P 30/10 was significantly (P = 0.03) higher during the decremental phase. Concomitantly, (P[A-a]O2) decreased by 28% from a baseline of 210.6 mm Hg to a minimal value of 151.6 mm Hg at P 35/15 during the decremental PEEP titration phase. The decrease from baseline was significant (P = 0.03) at P 30/10 (167.2 mm Hg). When compared with the incremental PEEP titration phase at P 30/10, (P[A-a]O2) was significantly (P = 0.03) lower during the decremental phase. The calculated shunt fraction at baseline was 6.2% and decreased by 19% to a value of 5% during the decremental PEEP titration phase (P 30/10; P = 0.03). The shunt fraction was significantly (P = 0.03) lower during the decremental phase of the PEEP titration at P 30/10, compared with the respective airway setting during the incremental phase. The PaCO2 decreased from 40.2 mm Hg at baseline to 27.6 mm Hg at P 55/20. This represented a decrease of 38% (P = 0.03). The PaCO2 was 30.9 mm Hg at final IPPV (P = 0.04), a value significantly (P = 0.04) lower than that at baseline.
Median and range values of respiratory variables measured during spontaneous breathing (SB), at IPPV at a PIP of 20 cm H2O and a PEEP of 0 cm H2O (P 20/0) during which baseline (BL) values were established, at the incremental phase of the PEEP titration (P 25/5 to P 40/20), at the recruitment maneuver (P 40/20 to P 55/20), at the decremental phase of the PEEP titration (P 40/20 to P 25/5), and at the final IPPV period (P 20/0) during total IV anesthesia in 6 ponies.
PIP/PEEP | VT (mL/kg) | PaO2 (mm Hg) | (P[A-a]O2) (mm Hg) | Cdyn (mL/cmH2O) | PaCO2 (mm Hg) | |||||
---|---|---|---|---|---|---|---|---|---|---|
(cm H2O) | Median | Range | Median | Range | Median | Range | Median | Range | Median | Range |
SB | 7 | 5–15 | 368.9 | 207.6–469.1 | 265.0 | 155.9–361.4 | 46.5 | 42.0–53.8 | ||
P 20/0 BL | 14 | 10–17 | 441.3 | 390.4–460.4 | 210.6 | 160.2–237.8 | 90.5 | 63.0–112.4 | 40.2 | 25.4–45.2 |
P 25/5 | 14 | 10–17 | 425.2 | 387.6–446.9 | 211.6 | 179.5–230.0 | 99.5 | 67.0–117.0 | 38.2 | 25.8–40.7 |
P 30/10 | 13 | 10–16 | 423.0 | 359.5–438.7 | 212.2 | 187.2–250.3 | 94.0 | 67.0–109.9 | 38.0 | |
P 35/15 | 13 | 9–15 | 406.9 | 371.5–505.2 | 214.3 | 134.4–281.2 | 93.4 | 79.0–110.3 | 39.2 | 33.8–43.6 |
P 40/20 | 13 | 12–15 | 450.4 | 376.2–459.9 | 176.9 | 174.0–234.7 | 95.9 | 74.0–106.7 | 39.0 | 35.6–45.2 |
P 45/20 | 17 | 17–20 | 473.0 | 420.7–489.3 | 165.6 | 136.8–201.5 | 109.5 | 90.0–116.7 | 33.6 | 29.0–37.4 |
P 50/20 | 20 | 19–25 | 459.0 | 413.4–532.2 | 182.5 | 113.5–210.2 | 106.5 | 92.0–122.6 | 31.1 | 23.8–31.8 |
P 55/20 | 23 | 15–29 | 475.5 | 417.9–542.9 | 159.2 | 104.1–230.9 | 104.0 | 91.0–122.7 | 27.6* | 20.9–30.5 |
P 40/20 | 16 | 15–20 | 463.2 | 404.1–507.3 | 175.6 | 128.1–239.4 | 124.0 † | 105.0–147.4 | 29.4 | 23.7–33.3 |
P 35/15 | 19 | 17–23 | 495.1 | 326.1–535.4 | 151.6 | 109.7–318.7 | 139.0 † | 120.0–165.2 | 28.4 | 22.3–31.9 |
P 30/10 | 22 | 17–25 | 479.1*† | 460.6–514.0 | 167.2*† | 122.9–194.9 | 147.0*† | 122.0–172.7 | 27.5 | 22.4–29.4 |
P 25/5 | 21 | 17–26 | 468.8 | 392.7–495.2 | 176.2 | 131.7–357.5 | 137.0 † | 112.0–163.7 | 27.5 | 22.6–30.2 |
P 20/0 | 16 | 13–22 | 445.2 | 356.0–494.6 | 177.9 | 131.5–296.3 | 120.4* | 89.0–155.7 | 30.9* | 25.8–34.9 |
Significantly (P < 0.05) different from baseline value.
Significantly (P < 0.05) different from the value recorded at the same airway pressure during the incremental PEEP titration phase.
When IPPV began after spontaneous breathing, MAP decreased by 12% and CO decreased by 15% (Table 2). Mean arterial blood pressure decreased further during the incremental PEEP titration and the RM by 21% from a baseline value of 115.5 mm Hg to 90.5 mm Hg at P 55/20 (P = 0.03). During the decremental PEEP titration phase, MAP returned to a value of 109 mm Hg at final IPPV (P = 0.03; Figure 3). In 1 individual pony, high MAP values were recorded, which explains the great variations in MAP. The HR increased from a baseline value of 35 beats/min to 41 beats/min at P 55/20 (P = 0.03) and decreased to baseline values at final IPPV (P = 0.03; Figure 3). In 1 pony, measurement of CO was not possible because of technical reasons, and data from this pony were excluded from statistical analyses. In the remaining 5 ponies, CO decreased slightly during RM (5.2 L/min at baseline to 4.3 L/min at P 55/20). Cardiac index at baseline was 41 mL/kg/min and decreased to 33.3 mL/kg/min at P 55/20.
Median and range values of hemodynamic variables measured during SB, at IPPV (P 20/0) during which BL was established, at the incremental phase of the PEEP titration (P 25/5 to P 40/20), at the recruitment maneuver (P 40/20 to P 55/20), at the decremental phase of the PEEP titration (P 40/20 to P 25/5), and at the final IPPV period (P 20/0) during total IV anesthesia in 6 ponies.
PIP/PEEP | MAP (mm Hg) | HR (bpm) | CO (L/min) | CI (mL/kg/min) | Shunt (%) | |||||
---|---|---|---|---|---|---|---|---|---|---|
(cm H2O) | Median | Range | Median | Range | Median | Range | Median | Range | Median | Range |
SB | 104.0 | 96.0–148.0 | 34 | 30–42 | 5.8 | 5.0–6.9 | 49.8 | 36.2–80.5 | 8.1 | 4.0–13.0 |
P 20/0 (BL) | 115.5 | 97.0–147.0 | 35 | 32–37 | 5.2 | 3.6–5.9 | 41.0 | 26.0–42.8 | 6.2 | 5.1–8.8 |
P 25/5 | 113.5 | 98.0–150.0 | 34 | 30–39 | 4.5 | 3.8–5.8 | 35.4 | 28.3–42.0 | 6.4 | 5.1–10.0 |
P 30/10 | 113.0 | 95.0–143.0 | 34 | 30–41 | 4.3 | 3.6–5.4 | 36.2 | 28.3–39.0 | 6.9 | 5.2–10.6 |
P 35/15 | 112.0 | 106.0–135.0 | 35 | 30–45 | 3.9 | 3.3–5.9 | 32.4 | 25.4–42.8 | 6.4 | 3.1–11.2 |
P 40/20 | 103.5 | 92.0–143.0 | 38 | 30–49 | 4.6 | 3.0–5.8 | 34.6 | 28.3–42.0 | 6.1 | 4.1–8.4 |
P 45/20 | 96.5 | 89.0–134.0 | 41 | 34–50 | 4.2 | 3.0–6.1 | 31.6 | 29.4–44.2 | 4.6 | 3.7–10.7 |
P 50/20 | 95.5 | 81.0–130.0 | 41 | 35–48 | 4.2 | 2.8–5.6 | 32.3 | 26.1–40.6 | 4.9 | 2.7–7.7 |
P 55/20 | 90.5* | 84.0–130.0 | 41* | 33–48 | 4.3 | 2.9–5.3 | 33.3 | 28.4–38.4 | 4.9 | 3.5–8.8 |
P 40/20 | 94.0 | 85.0–136.0 | 40 | 31–49 | 4.5 | 3.3–5.1 | 33.3 | 32.3–37.0 | 4.9 | 4.1–8.5 |
P 35/15 | 99.0 | 85.0–131.0 | 38 | 32–47 | 4.5 | 3.5–5.5 | 34.3 | 28.1–41.4 | 5.5 | 3.2–7.3 |
P 30/10 | 106.0 | 91.0–136.0 | 35 | 30–43 | 4.2 | 3.5–5.4 | 32.6 | 27.5–40.6 | 5.0*† | 3.6–7.8 |
P 25/5 | 108.8 | 89.0–137.0 | 34 | 30–44 | 4.0 | 3.5–7.0 | 32.6 | 27.5–52.6 | 5.1 | 4.2–10.7 |
P 20/0 | 109.0 | 84.0–133.0 | 37 | 30–40 | 4.0 | 3.6–4.5 | 30.9 | 26.1–35.3 | 5.6 | 3.9–12.4 |
bpm = Beats per minute.
See Table 1 for remainder of key.
Except for 1 pony, recovery from anesthesia after IV administration of sarmazenil was quick and no complications were detected. Because of persistent excitatory behavior after administration of the antagonist, 1 pony required resedation with an IV bolus of detomidine.
Discussion
The main finding of our study was that an alveolar RM caused only minor cardiovascular effects and, clinically, no adverse pulmonary effects in healthy ponies undergoing TIVA anesthesia. Furthermore, significant changes in Cdyn and PaO2 during PEEP titration were detected, thus providing the possibility of systematic identification of an optimal PEEP. This open lung PEEP should prevent closure of alveoli that are opened by a preceding RM.
As expected, some alterations in cardiovascular parameters were recorded: first, when IPPV was substituted for spontaneous breathing, and second, when an RM was superimposed on IPPV. During the RM, MAP and CO decreased further, compared with baseline; the maximal decrease occurred at maximal airway pressures. The reduction in MAP was significant and is thought to have been caused by increased intrathoracic pressure, which increases impedance to blood flow through the lungs, thus causing a diminished end-dias-tolic left ventricular volume.44 To our knowledge, there are no studies in equids documenting the hemodynamic effects of PEEP when combined with such high peak airway pressures as performed in the study reported here. The recorded decrease in CO was small, compared with results of other studies38,39 with sustained increases in airway pressures. It is likely that the concomitant increase in HR during the RM partially compensated for decreased venous return and hence CO. In horses anesthetized with halothane, MAP and CO decreased by 27% and 16%, respectively, when a PEEP of 10 cm H2O was added to IPPV.38 In ponies in which anesthesia was administered IV, CO decreased by 24% and 51% and MAP decreased by 7% and 12% after PEEP of 20 and 30 cm H2O, respectively.39 In humans, IV administration of fluids has been advocated during an RM when signs of hemodynamic instability appear, and it has been found that the hemodynamic effects of PEEP may be minimized by normovolemia or hypervolemia.45,46 In the study reported here, lactated Ringer's solution was infused at 10 mL/kg/h starting at induction of anesthesia and was maintained at this rate until the end of the procedure. No attempt was made to precondition ponies with increased fluid load before starting the RM.
Intermittent bolus thermodilution is well documented as a method for measurement of CO in equids. In humans, there is clinically acceptable agreement between the CCO measurement method and the classical intermittent thermodilution method.47,48 In calves with a body weight of 70 kg, CCO had higher accuracy and greater resistance to thermal noise than standard bolus measurements.49 The method of CCO measurementd has not been validated in ponies. However, size and weight of ponies in our study were on the same order of magnitude and in the range encountered in adult humans. This allowed correct positioning of the pulmonary artery catheter in the study reported here and suggests that a similar precision of CO measurement can be expected. In our study, we emphasized trends of CO during the influence of changing airway pressures, rather than absolute values.
During a PEEP titration–RM sequence in humans, an increase in Cdyn and an increase in PaO2 suggest recruitment of previously collapsed lung areas.16 In our study, the marked and sustained increase in Cdyn (maximal >62% at P 30/10 in the decremental PEEP titration phase), and the fact that Cdyn remained high after the RM at final IPPV, suggested successful recruitment of lung tissue because the formation of atelectasis is associated with a decrease in Cdyn.16,50 However, this marked increase in Cdyn caused a significant, but only small, improvement in oxygenation. This finding may be associated with the high baseline PaO2 (441.3 mm Hg) in ponies in our study, compared with values generally detected in anesthetized adult horses breathing 100% oxygen. In the study reported here, the maximal median PaO2 was recorded at P 35/15 (495.1 mm Hg), but compared with baseline, the increase from baseline at this sampling point did not reach significance because of 1 comparatively low PaO2 value (326.1 mm Hg) recorded in 1 individual pony that caused great variations in our data. At the next step of the decremental PEEP titration phase (P 30/10), the increase in PaO2 was significant at an absolute PaO2 value that was lower that that at the previous step. The fact that the ponies had a high baseline PaO2 and little venous admixture may be associated with the anesthetic protocol used. It is recognized that isoflurane and halothane cause dose-related cardiovascular depres-51,52 In contrast, TIVA in ponies given detomidine, ketamine, and guaifenesin53 or ketamine and climazolam54 had minimal depressant effects on cardiorespiratory parameters. In the study reported here, CI was nevertheless low, compared with results of those studies. However, in those studies,53,54 the measurements were obtained during spontaneous respiration. In our study, IPPV and RM were used and the accompanying increase in mean airway pressure negatively influenced CI. Ketamine is the only drug that has a beneficial effect on anesthesia-induced atelectasis because it does not impair muscle tone of respiratory muscles.55 Hypoxic pulmonary vasoconstriction appears to be an important protective mechanism that optimizes ventilation-perfusion matching and gas exchange in the lungs. In ponies in lateral recumbency, HPV was found to be responsible for redistribution of blood flow from dependent to non-dependent lung areas.56 Results of several studies indicate that all inhalation anesthetics decrease HPV and that narcotics, benzodiazepines, and barbiturates57 as well as ketamine58 have no detectable effect. In our study, it is possible that ponies were well oxygenated because of a better-preserved HPV as a result of the TIVA protocol used.
In the study reported here, the RM did provoke a decrease in the shunt fraction as detected in humans in which a successful RM is accompanied by an increase in PaO2 and a decrease in shunt fraction.50 The shunt fraction was low; at baseline, the shunt fraction was 6.2%, and at P 30/10 of the decremental PEEP titration, the shunt fraction was 5%. In ponies in which anesthesia was administered IV, Wilson and Soma39 recorded a decrease in shunt fraction from 12.9% (IPPV) to an absolute value of 7.5% when using a PEEP of 20 cm H2O whereby tissue oxygen delivery was decreased. In spontaneously breathing horses anesthetized with halothane, pulmonary shunt was 20% to 25%, which decreased to 15% when horses were ventilated,1 and during IPPV (P 30/0), shunt fractions of 21% have been calculated.4 In our study, the shunt fraction was low, although ponies were breathing 100% oxygen. It has been found that a high FIO2 of 1.0 promotes the formation of atelectasis and shunt in humans59 as well as in horses.q
To prevent recruited alveoli from collapsing, PEEP must be applied after alveolar recruitment. An optimal PEEP is the lowest value of PEEP necessary to keep the lung tissue open. To find optimal PEEP, the closing pressure has to be determined for each animal. In our study, changes in Cdyn and changes in arterial oxygenation were investigated. A decrease in PaO2 and Cdyn during the decremental steps of PEEP titration is considered a sign of alveolar closing; they mark the pressure at which collapse (derecruitment) of lung tissue occurs. The distinct decrease in PaO2 and in Cdyn occurred at slightly different airway pressures (PaO2 decreased at P 30/10 and Cdyn at P 25/5 of the decremental PEEP titration phase), and this finding is in agreement with results of studies60,61 in human patients. On 1 hand, PEEP prevents alveoli from collapsing while simultaneously distending other alveoli. High PEEP distends more lung tissue, thus causing decreased lung compliance. When PEEP is decreased from a state of distension, compliance initially increases to the point at which recollapse of unstable lung alveoli occurs, which finally leads to decreased compliance again.
Despite the scheduled reduction in the respiratory rate during the RM, the PaCO2 decreased to a minimal value of 27.6 mm Hg at P 55/20 as a sequel of the increased alveolar ventilation. Even at final IPPV, PaCO2 was significantly lower than the baseline value. Hypocapnia (PaCO2 <30 mm Hg) should be avoided because it carries the risk of decreased cerebral blood flow62 and diminished catecholamine release with debilitation of the cardiovascular system.63 Prevention of excessive hypocapnia during RM is facilitated by continuous monitoring of PaCO2 and includes a reduction of the respiratory rate; limiting ΔP by increasing PEEP; or, alternatively, the addition of CO2 to the inspiratory gas.
In the study reported here, no evidence of barotrauma during or after anesthesia was detected. This was not unexpected because it is in agreement with findings in animals and humans applying similar airway pressures. In a sheep model of ARDS, high-pres-sure (P 60/40) short-term and repetitive RMs were applied safely without sustained hemodynamic compromise and histologic injury to the lungs.64 Absence of barotrauma was also reported in the clinical setting for human patients by use of airway pressures of 50 to 65 cm H2O (VT of 18 mL/kg) during general anesthesia16 or even 80 cm H2O in patients with ARDS and chest trauma.62–67 Results of 1 study24 indicate that it is not the high airway pressure but rather the large regional VT that causes lung injury.24 In our study, a VT of as much as 23 mL/kg was used. Healthy adult sheep ventilated with a VT of 50 to 70 mL/kg (PIP, 50 cm H2O) developed severe respiratory failure.68
For the statistical analyses, a conservative approach was used. The Wilcoxon signed rank test was used because a small sample size (6 ponies) was used for statistical analyses, and therefore, normal distribution of the data was not ensured.
On the basis of the results of our study, further research on cardiorespiratory effects of RM, inhalation anesthetics, and hypovolemic states in equids is warranted. Tissue oxygen delivery and uptake measured during RM in equids during hypoxic states would be ideal measures of successful treatment of hypoxemia.
The PEEP titration and RM described in the study reported here resulted in only limited cardiovascular compromise despite use of high PEEP and peak airway pressures. Although baseline oxygenation was high, there was a significant increase in PaO2 and decrease in shunt attributable to the RM. Evaluation of PaO2 and Cdyn in the decremental phase of the PEEP titration permitted detection of an alveolar closing pressure.
(P[A–a]O2) | Alveolar-to-arterial partial pressure difference of oxygen |
FIO2 | Inspired oxygen fraction |
CO | Cardiac output |
CT | Computed tomography |
PIP | Peak inspiratory pressure |
PEEP | Positive end-expiratory pressure |
RM | Recruitment maneuver |
ARDS | Acute respiratory distress syndrome |
CI | Cardiac index |
IPPV | Intermittent positive pressure ventilation |
TIVA | Total intravenous anesthesia |
VT | Tidal volume |
VM | Minute volume |
Cdyn | Dynamic compliance |
HR | Heart rate |
CCO | Continuous cardiac output |
Pv̄O2 | Partial pressure of O2 in mixed venous blood |
Sv̄O2 | Mixed venous oxygen saturation of hemoglobin |
Hb | Hemoglobin |
Hb | Hemoglobin |
ΔP | Constant airway pressure difference |
MAP | Mean arterial pressure |
HPV | Hypoxic pulmonary vasoconstriction |
McDonnell W. The effect of anaesthesia on pulmonary gas exchange and arterial oxygenation in the horse. PhD thesis, Department of Clinical Veterinary Medicine, University of Cambridge, Cambridge, UK, 1974.
Pauritsch K. Positive end-expiratory pressure ventilation in combination with end-inspiratory breath-holding during anaesthesia in colic horses. PhD thesis, Horse Clinic, Tierärztliche Hochschule Hannover, Hannover, Germany, 1997.
Domosedan, Pfizer AG, Zürich, Switzerland.
Continuous thermodilution Swan-Ganz catheter, Vigilance System, Courtesy of Edwards Lifesciences, Irvine, Calif.
Climasol, Dr. E. Gräub AG, Bern, Switzerland.
Narketan 10, Vétoquinol AG, Belp, Switzerland.
VMS, MATRX Veterinary Equipment, Crans-Montana, Switzerland.
μVP-2001 VOLUMED, Arcomed AG, Regensdorf, Switzerland.
Lactated Ringer's solution, Laboratorium Bichsel AG, Interlaken, Switzerland.
Servo 300, Siemens-Elema, Electromedical Systems Division, Solna, Sweden.
Sarmasol, Dr. E. Gräub AG, Bern, Switzerland.
Xylocain 2%, Astra Pharmaceutica AG, Dietikon, Switzerland.
OPTIVA*2 IV catheter, Johnson & Johnson Medical, Arlington, Tex.
Cosmo/VenTrak, Novametrix Medical Systems Inc, Wallingford, Conn.
AS5 compact anesthesia monitor, GE Healthcare Datex-Ohmeda Corp, Helsinki, Finland.
pH/blood gas-system, Serie 840 Bayer, Ciba Corning Diagnostics GmbH, Dietlikon, Switzerland.
Marntell S. Sedation and dissociative anaesthesia in the horse-physiological and clinical aspects. PhD thesis, Department of Large Animal Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden, 2004.
References
- 1↑
Hall LWGillespie JRTyler WS. Alveolar-arterial oxygen tension differences in anaesthetized horses. Br J Anaesth 1968; 40: 560–568.
- 2
Gillespie JRTyler WSHall LW. Cardiopulmonary dysfunction in anesthetized, laterally recumbent horses. Am J Vet Res 1969; 30: 61–72.
- 3
Schatzmann UKoehli MDudan F, et al.Effect of postural changes on certain circulatory and respiratory values in the horse. Am J Vet Res 1982; 43: 1003–1005.
- 4↑
Nyman GHedenstierna G. Ventilation-perfusion relationships in the anaesthetised horse. Equine Vet J 1989; 21: 274–281.
- 5
Mitchell BLittlejohn A. Influence of anaesthesia and posture on arterial oxygen and carbon dioxide tensions, alveolar dead space and pulse rate in the horse. Proc Assoc vet Anaesth 1972; 3: 61–74.
- 6
Steffey EPWheat JDMeagher DM, et al.Body position and mode of ventilation influences arterial pH, oxygen, and carbon dioxide tensions in halothane-anesthetized horses. Am J Vet Res 1977; 38: 379–382.
- 7↑
Stegmann GFLittlejohn A. The effect of lateral and dorsal recumbency on cardiopulmonary function in the anaesthetised horse. J S Afr Vet Assoc 1987; 58: 21–27.
- 8↑
Moens YLagerweij EGootjes P, et al.Distribution of inspired gas to each lung in the anaesthetised horse and influence of body shape. Equine Vet J 1995; 27: 110–116.
- 9↑
Nyman GFunkquist BKvart C, et al.Atelectasis causes gas exchange impairment in the anaesthetised horse. Equine Vet J 1990; 22: 317–324.
- 10↑
Hedenstierna GLundquist HLundh B, et al.Pulmonary densities during anaesthesia. An experimental study on lung morphology and gas exchange. Eur Respir J 1989; 2: 528–535.
- 11
Bendixen HHedley-Whyte JLaver M. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation. N Engl J Med 1963; 269: 991–996.
- 12↑
Lundquist HHedenstierna GStrandberg A, et al.CT-assessment of dependent lung densities in man during general anaesthesia. Acta Radiol 1995; 36: 626–632.
- 13
Rothen HUNeumann PBerglund JE, et al.Dynamics of reexpansion of atelectasis during general anaesthesia. Br J Anaesth 1999; 82: 551–556.
- 14
Rothen HUSporre BEngberg G, et al.Re-expansion of atelectasis during general anaesthesia: a computed tomography study. Br J Anaesth 1993; 71: 788–795.
- 16↑
Tusman GBohm SHVazquez de Anda GF, et al.‘Alveolar recruitment strategy’ improves arterial oxygenation during general anaesthesia. Br J Anaesth 1999; 82: 8–13.
- 17
Böhm S. The open lung concept. In: Vincent J, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag Inc, 1998; 430–440.
- 18
Bein TKrenz DMaghsudi M, et al.Ventilation in prone position in a 5-year-old child after multiple trauma. Effective treatment of persistent atelectasis. Unfallchirurg 2000; 103: 787–790.
- 19
Dyhr TNygard ELaursen N, et al.Both lung recruitment maneuver and PEEP are needed to increase oxygenation and lung volume after cardiac surgery. Acta Anaesthesiol Scand 2004; 48: 187–197.
- 20
Mead JTakishima TLeith D. Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol 1970; 28: 596–608.
- 21
Steinberg JMSchiller HJHalter JM, et al.Alveolar instability causes early ventilator-induced lung injury independent of neutrophils. Am J Respir Crit Care Med 2004; 169: 57–63.
- 22
Papadakos PJLachmann B. The open lung concept of alveolar recruitment can improve outcome in respiratory failure and ARDS. Mt Sinai J Med 2002; 69: 73–77.
- 23
Halter JMSteinberg JMSchiller HJ, et al.Positive end-expiratory pressure after a recruitment maneuver prevents both alveolar collapse and recruitment/derecruitment. Am J Respir Crit Care Med 2003; 167: 1620–1626.
- 24↑
Dreyfuss DSaumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294–323.
- 25↑
Amato MBBarbas CSMedeiros DM, et al.Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347–354.
- 26
Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999; 116: 9S–15S.
- 27
Reis Miranda DGommers DStruijs A, et al.The open lung concept: effects on right ventricular afterload after cardiac surgery. Br J Anaesth 2004; 93: 327–332.
- 28↑
Auler JO JrCarmona MJBarbas CV, et al.The effects of positive end-expiratory pressure on respiratory system mechanics and hemodynamics in postoperative cardiac surgery patients. Braz J Med Biol Res 2000; 33: 31–42.
- 29↑
Bonnet FRichard CGlaser P, et al.Changes in hepatic flow induced by continuous positive pressure ventilation in critically ill patients. Crit Care Med 1982; 10: 703–705.
- 30↑
Nunes SRothen HUBrander L, et al.Changes in splanchnic circulation during an alveolar recruitment maneuver in healthy porcine lungs. Anesth Analg 2004; 98: 1432–1438.
- 31
Böhm SLachmann B. Respiratorische Therapiemassnahmen. In: Seeger W, ed. Lehrbuch der Internistischen Intensivtherapie. 3rd ed. New York: Schattauer, 1997; 35–85.
- 32
Neumann PRothen HUBerglund JE, et al.Positive end-expiratory pressure prevents atelectasis during general anaesthesia even in the presence of a high inspired oxygen concentration. Acta Anaesthesiol Scand 1999; 43: 295–301.
- 33↑
Böhm SBangert K. Prävention und Therapie anästhesiebedingter Atelektasen. Anaesthesist 2000; 49: 345–348.
- 34
Ward NSLin DYNelson DL, et al.Successful determination of lower inflection point and maximal compliance in a population of patients with acute respiratory distress syndrome. Crit Care Med 2002; 30: 963–968.
- 35
Baba RParamesh KZwaal JW. Protective ventilation of patients with acute respiratory distress syndrome (lett). Br J Anaesth 2004; 93: 153.
- 36
Weaver BMWalley RV. Ventilation and cardiovascular studies during mechanical control of ventilation in horses. Equine Vet J 1975; 7: 9–15.
- 37
Wilson DVMcFeely AM. Positive end-expiratory pressure during colic surgery in horses: 74 cases (1986–1988). J Am Vet Med Assoc 1991; 199: 917–921.
- 38↑
Swanson CRMuir WW III. Hemodynamic and respiratory responses in halothane-anesthetized horses exposed to positive end-expiratory pressure alone and with dobutamine. Am J Vet Res 1988; 49: 539–542.
- 39↑
Wilson DVSoma LR. Cardiopulmonary effects of positive end-expiratory pressure in anesthetized, mechanically ventilated ponies. Am J Vet Res 1990; 51: 734–739.
- 40
Mizuno YAida HHara H, et al.Cardiovascular effects of intermittent positive pressure ventilation in the anesthetized horse. J Vet Med Sci 1994; 56: 39–44.
- 41
Hodgson DSSteffey EPGrandy JL, et al.Effects of spontaneous, assisted, and controlled ventilatory modes in halothane-anesthetized geldings. Am J Vet Res 1986; 47: 992–996.
- 42
Nyman GHedenstierna G. Comparison of conventional and selective mechanical ventilation in the anaesthetized horse. Effects on central circulation and pulmonary gas exchange. Zentralbl Veterinarmed [A] 1988; 35: 299–314.
- 43↑
Lumb AB. Nunn's applied respiratory physiology. 5th ed. Oxford, England: Butterworth-Heinemann, 2000.
- 44↑
Rankin JSOlsen COArentzen CE, et al.The effects of airway pressure on cardiac function in intact dogs and man. Circulation 1982; 66: 108–120.
- 45
Schreuder JJJansen JRVersprille A. Hemodynamic effects of PEEP applied as a ramp in normo-, hyper-, and hypovolemia. J Appl Physiol 1985; 59: 1178–1184.
- 46
Qvist JPontoppidan HWilson RS, et al.Hemodynamic responses to mechanical ventilation with PEEP: the effect of hypervolemia. Anesthesiology 1975; 42: 45–55.
- 47
Ditmyer CEShively MBurns DB, et al.Comparison of continuous with intermittent bolus thermodilution cardiac output measurements. Am J Crit Care 1995; 4: 460–465.
- 48
Zollner CPolasek JKilger E, et al.Evaluation of a new continuous thermodilution cardiac output monitor in cardiac surgical patients: a prospective criterion standard study. Crit Care Med 1999; 27: 293–298.
- 49↑
Mihaljevic Tvon Segesser LKTonz M, et al.Continuous versus bolus thermodilution cardiac output measurements-a comparative study. Crit Care Med 1995; 23: 944–949.
- 50↑
Amato MBPBarbas CSVMedeiros DM, et al.Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 1835–1846.
- 51
Steffey EPHowland D Jr. Cardiovascular effects of halothane in the horse. Am J Vet Res 1978; 39: 611–615.
- 52
Steffey EPHowland D Jr. Comparison of circulatory and respiratory effects of isoflurane and halothane anesthesia in horses. Am J Vet Res 1980; 41: 821–825.
- 53↑
Taylor PMKirby JJShrimpton DJ, et al.Cardiovascular effects of surgical castration during anaesthesia maintained with halothane or infusion of detomidine, ketamine and guaifenesin in ponies. Equine Vet J 1998; 30: 304–309.
- 54↑
Bettschart-Wolfensberger RTaylor PMSear JW, et al.Physiologic effects of anesthesia induced and maintained by intravenous administration of a climazolam-ketamine combination in ponies premedicated with acepromazine and xylazine. Am J Vet Res 1996; 57: 1472–1477.
- 55↑
Tokics LStrandberg ABrismar B, et al.Computerized tomography of the chest and gas exchange measurements during ketamine anaesthesia. Acta Anaesthesiol Scand 1987; 31: 684–692.
- 56↑
Stolk PWT. The effect of anesthesia on pulmonary blood flow in the horse, in Proceedings. Assoc Vet Anaesth G B Irel 1982;119–129.
- 57↑
Marshall BMarshall C. Anesthesia and pulmonary circulation. In: Covino BFozzard HRehder K, et al, eds. Effects of anesthesia. Bethesda, Md: American Physiological Society, 1985; 121–136.
- 58↑
Nakayama MMurray PA. Ketamine preserves and propofol potentiates hypoxic pulmonary vasoconstriction compared with the conscious state in chronically instrumented dogs. Anesthesiology 1999; 91: 760–771.
- 59↑
Rothen HUSporre BEngberg G, et al.Prevention of atelectasis during general anaesthesia. Lancet 1995; 345: 1387–1391.
- 60
Muscedere JGMullen JBGan K, et al.Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149: 1327–1334.
- 61
Suter PMFairley BIsenberg MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med 1975; 292: 284–289.
- 63↑
Low JMGin TLee TW, et al.Effect of respiratory acidosis and alkalosis on plasma catecholamine concentrations in anaesthetized man. Clin Sci (Lond) 1993; 84: 69–72.
- 64↑
Fujino YGoddon SDolhnikoff M, et al.Repetitive high-pressure recruitment maneuvers required to maximally recruit lung in a sheep model of acute respiratory distress syndrome. Crit Care Med 2001; 29: 1579–1586.
- 65
Povoa PAlmeida EFernandes A, et al.Evaluation of a recruitment maneuver with positive inspiratory pressure and high PEEP in patients with severe ARDS. Acta Anaesthesiol Scand 2004; 48: 287–293.
- 66
Schreiter DReske AGlien C, et al.Ventilation by the open lung concept in spite of traumatic lung herniation. Br J Anaesth 2003; 90: 385–387.
- 67
Schreiter DReske AStichert B, et al.Alveolar recruitment in combination with sufficient positive end-expiratory pressure increases oxygenation and lung aeration in patients with severe chest trauma. Crit Care Med 2004; 32: 968–975.
- 68↑
Kolobow TMoretti MPFumagalli R, et al.Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 1987; 135: 312–315.